期刊文献+

炎症介质对脑损伤患者呼吸机相关性肺炎的早期诊断和预测 被引量:3

Prognostic role of inflammatory media to identify early ventilator-associated pneumonia brain injury
暂未订购
导出
摘要 目的对脑损伤呼吸机相关性肺炎患者进行早期预测及诊断。方法选择脑损伤并且施行有创机械通气的患者55例。所有患者在入ICU机械通气第1天(D1)时测定:CPIS、PCT、CRP、IL-6和进行气管抽吸物培养。入ICU机械通气第4天(D4)对上述指标进行重新测定,并对数据进行统计学分析。结果 PCT预测早期VAP的敏感性为83.3%,特异性为77.4%;IL-6预测早期VAP的敏感性为70.8%,特异性为64.5%;CRP预测早期VAP的敏感性为62.5%,特异性为61.3%。PCT与CPIS在诊断早期VAP时具有较强的相关性,其相关系数r=0.853(P<0.05)。结论血清PCT水平对预测脑损伤患者早期VAP的敏感性及特异性高于CRP及IL-6。联合监测CPIS可能有助于提高早期VAP的诊断。 【Objective】To early anticipate and diagnose ventilator associated pneumonia in patients with cerebral injuries. 【Methods】55 cerebral injury patients on ventilator admitted were chosen as the study subjects. The following parameters were examined on the 1st day(D1) on ventilator: CPIS score, PCT, CRP, IL-6, and aspirate was collected from trachea for cultivation. All the above examinations were repeated on the 4th day on ventilator(D4). All data were statistically analyzed. 【Results】The sensitivity of PCT for predicting early VAP was 83.3%, specificity77.4%; the sensitivity of IL-6 for predicting early VAP was 70.8%, specificity 64.5%; the sensitivity of CRP for predicting early VAP was 62.5%, specificity 61.3%. PCT and CPIS were strongly correlated with early VAP, with a correlation coefficient r =0.853(P〈 0.05).【Conclusions】Serum PCT level has higher sensitivity and specificity to predict early VAP than CRP and IL-6. Monitoring serum PCT may be helpful for anticipating early VAP, and combination with monitoring CPIS may be helpful to improve diagnosis of early VAP.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第24期65-68,共4页 China Journal of Modern Medicine
关键词 炎症介质 脑损伤 呼吸机相关性肺炎 早期诊断和预测 inflammatory media cerebral injury ventilator associated pneumonia early diagnosis and anticipation
  • 相关文献

参考文献13

  • 1王青萍.呼吸机相关性肺炎的临床新进展[J].国际呼吸杂志,2010(14):865-867. 被引量:5
  • 2陈琳,蒋亚斌.呼吸机管道更换时间与呼吸机相关性肺炎发生相关性的Meta分析[J].中国现代医学杂志,2011,21(12):1471-1475. 被引量:10
  • 3Chinese TORRES A, EWIG S, LODE H, et al. Hospital-acquired pneu- monia in Europe[J]. Eur Respir J, 2009, 33: 951-952.
  • 4PIERRAKOS C, VINCENT JL. Sepsis biomarkers: A review[J]. Crit Care, 2010, 14: R15.
  • 5LEVY MM, DELLINGER RP, TOWNSEND SR, et al. The sur- viving sepsis campaign: Results of an international gnide- line-based performance improvement program targeting severe sepsis[J]. Intensive Care Med, 2010, 36: 222-231.
  • 6FERRER R, ARTIGAS A, SUAREZ D, et al. Effectiveness of treatments for severe sepsis: A prospective, muhicenter, observa- tional study[J]. Am J Respir Crit Care Med, 2009, 180: 861-866.
  • 7谭家香,张旺龙,周锦贤,梁琼仙,温嘉强.持续气囊上方低负压吸引预防呼吸机相关性肺炎的临床观察[J].中国现代医学杂志,2012,22(1):83-85. 被引量:2
  • 8BECKER KL, R SNIDER, ES NYLEN. Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations[J]. Crit. Care Med, 2008, 36: 941-952.
  • 9MOULIN F, RAYMOND J, LORROT M, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia [J]. Arch Dis Child, 2001, 84: 332-336.
  • 10孔怡淳,任新生.前降钙素与危重病[J].中国危重病急救医学,2004,16(2):124-126. 被引量:33

二级参考文献66

共引文献68

同被引文献34

引证文献3

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部